Abstract
Use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a potential option to bridge critically unwell patients to heart transplantation. However, given the critically unwell nature of this patient cohort, morbidity and mortality are expectedly high, with previous literature reporting 30-day mortality of up to 30%. This study investigated the mortality of patients on preoperative VA-ECMO prior to heart transplantation in a single Australian centre.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
